"The company is in the process of this natural sea based 100 per cent vegetarian product tenatatively by April 2015," Celestial Biolabs said in a filing to the BSE.
Earlier in 2013, the Hyderabad-based company launched its patented arthiritis management product, Cadalmin GAe.
Celestial Biolabs is currently engaged in the business of manufacturing and sale of bio-pharmaceutical products.
Shares of the company today closed at Rs 47.40 on the BSE, up 5.22 per cent from previous close.